Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Expression and Purification of Human Solute Carrier Transporters Using Codon-Optimized Genes
Published on: September 29, 2023
Roles and therapeutic targeting of SLC transporters in gastrointestinal malignancies
Junshu Wang1, Xiaoyu Huang1, Shuyi Chen2
1State Key Laboratory of Holistic, Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, 710038, China; Department of Gastroenterology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, China.
Abstract:
The solute carrier (SLC) transporter family, serving as metabolic gatekeepers, transports a range of substrates (nutrients, metabolites, ions, drugs) and regulates key physiological processes (proliferation, migration, angiogenesis, chemoresistance, immunomodulation, energy metabolism). Gastrointestinal malignancies are a leading cause of cancer-related deaths globally, marked by high prevalence and aggressive growth. Metabolic reprogramming, as an emerging cancer hallmark, promotes uncontrolled tumour proliferation. It dynamically adjusts the distribution of nutrients and energy in the tumour microenvironment, thereby regulating specific cellular processes. SLC transporters are widely expressed in the gastrointestinal tract, and their dysfunction can significantly affect tumour growth. Understanding the complex crosstalk between SLCs, cancer cell metabolism, and the tumour microenvironment is crucial for developing novel therapies. This review summarises the roles of SLCs in various oncogenic behaviours of gastrointestinal tumors, explains how their expression patterns and genetic variations contribute to chemoresistance, and assesses the clinical value of targeting SLC family proteins for therapeutic purposes.
Insights
Solute carrier (SLC) transporters regulate cell metabolism and are crucial in gastrointestinal cancers. Targeting these transporters offers a promising therapeutic strategy for improving cancer treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Metabolism
Background:
- Gastrointestinal malignancies are a major global health concern with high mortality rates.
- Metabolic reprogramming is a key hallmark of cancer, driving uncontrolled tumor proliferation.
- Solute carrier (SLC) transporters play vital roles in nutrient and metabolite transport, influencing cancer cell behavior.
Purpose of the Study:
- To review the multifaceted roles of SLC transporters in gastrointestinal tumor oncogenesis.
- To elucidate the contribution of SLC expression patterns and genetic variations to chemoresistance.
- To assess the therapeutic potential of targeting SLC family proteins in gastrointestinal cancers.
Main Methods:
- Literature review of studies on SLC transporters in gastrointestinal malignancies.
- Analysis of SLC expression patterns and genetic variations in relation to tumor behavior and chemoresistance.
- Evaluation of preclinical and clinical data on SLC-targeted therapies.
Main Results:
- SLC transporters are implicated in various oncogenic behaviors, including proliferation, migration, and angiogenesis.
- Altered SLC expression and genetic variations are linked to chemoresistance in gastrointestinal tumors.
- Targeting specific SLC transporters shows potential for novel therapeutic interventions.
Conclusions:
- SLC transporters are critical regulators of cancer cell metabolism and are significantly involved in gastrointestinal tumor progression and treatment resistance.
- Understanding the SLC-cancer cell metabolism-tumor microenvironment axis is essential for developing effective therapies.
- Targeting SLC family proteins represents a promising avenue for future gastrointestinal cancer treatment strategies.
More Related Videos
11:27Methods to Study Epithelial Transport Protein Function and Expression in Native Intestine and Caco-2 Cells Grown in 3D
Published on: March 16, 2017
06:19Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
Related Concept Videos
Secondary Active Transport
Secondary Active Transport
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Active Transport
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists